封面
市場調查報告書
商品編碼
1928562

豬瘟病毒PCR試劑盒市場,依檢測類型、技術、樣本類型、通路和最終用戶分類,全球預測,2026-2032年

African Swine Fever Virus PCR Kit Market by Test Type, Technology, Sample Type, Distribution Channel, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年豬瘟病毒 PCR 試劑盒市值為 1.9812 億美元,預計到 2026 年將成長至 2.1624 億美元,年複合成長率為 6.39%,到 2032 年將達到 3.0584 億美元。

主要市場統計數據
基準年 2025 1.9812億美元
預計年份:2026年 2.1624億美元
預測年份:2032年 3.0584億美元
複合年成長率 (%) 6.39%

全面介紹經典豬瘟病毒PCR試劑盒:重點在於診斷需求、性能標準和策略效用

非洲豬瘟病毒(ASFV)仍然是商業豬場面臨的最嚴重的動物健康威脅之一,而基於PCR的診斷方法是快速檢測、疫情控制和出口檢驗工作流程的核心。專門針對ASFV設計的PCR試劑盒能夠靈敏快速地檢測病毒DNA,從而支持公共衛生反應、獸醫監測和貿易合規。在過去十年中,高性能PCR檢測方法的引入已將診斷方法從被動確認轉變為主動監測,從而能夠更早地進行干預並更精確地繪製流行病學地圖。

分析正在重塑經典豬瘟病毒PCR試劑盒的開發、實施和診斷工作流程的變革性技術和監管變化

非洲豬瘟病毒(ASFV)PCR檢測試劑盒的診斷格局正經歷著一場變革,其驅動力包括技術的快速成熟、監管力度的加強以及終端用戶需求的不斷變化。在技​​術層面,檢測方法正從傳統的即時PCR轉向以絕對定量和抑制劑抗性為優先的專用平台。這一轉變反映了更廣泛的趨勢,即檢測方法不再局限於簡單的病毒存在/缺失檢測,而是著重於了解疾病進展和病毒載量動態,從而指南防治策略。同時,等溫擴增方法因其設備簡單、熱處理要求低,在分散式檢查中日益普及,擴大了診斷方法在資源匱乏地區的適用性。

評估2025年美國關稅對供應鏈、試劑採購、定價和PCR診斷試劑盒取得的累積影響

2025年美國關稅調整為購買非洲豬瘟(ASFV)PCR試劑盒及相關耗材的機構帶來了新的挑戰。這些措施影響了整個價值鏈的成本結構,凸顯了籌資策略和供應來源多元化的重要性。對於診斷研發公司和實驗室網路而言,當務之急是重新評估供應商合約、探索區域採購方案以及重新協商物流條款,以降低到岸成本波動帶來的風險。實際上,採用集中採購模式的實驗室可能會轉向多供應商策略或轉向本地化試劑生產,以維持成本可控性和供應連續性。

詳細的細分分析揭示了技術、測試類型、樣本類型、最終用戶和分銷管道的差異如何影響產品採用趨勢和產品策略。

細分市場分析清楚揭示了非洲豬瘟病毒(ASFV)PCR試劑盒市場中創新與需求交會之處。按技術分類,該市場由數位PCR、等溫PCR和即時PCR平台組成。在數位PCR領域,液滴數位PCR和微流體數位PCR在絕對定量和分級分離策略方面展現出顯著優勢。同時,等溫PCR又分為恒溫環型核酸擴增)和重組聚合酵素擴增(RPA),後者適用於分散式和資源匱乏的環境。即時PCR憑藉SYBR Green和TaqMan探針化學技術,兼顧了成本、特異性和儀器相容性,從而保持了廣泛的效用。這種技術多樣性影響產品定位,並進而影響儀器和耗材的商品搭售策略。

比較不同區域的診斷環境,可以發現需求促進因素、監管複雜性和基礎設施的差異。

區域趨勢將對非洲豬瘟病毒PCR試劑盒的診斷取得、營運限制和市場推廣策略產生重大影響。在美洲,一體化的商業化養豬生產系統、跨境貿易考慮以及注重通量、認證和可追溯性的成熟檢測網路正在塑造診斷需求。這有利於提供穩健的批量處理、標準化耗材和檢驗的工作流程的解決方案,而完善的物流系統則支援即時供應模式。隨著我們從北向南推進,公共部門監測計畫與私營部門的整合將改變對檢測複雜性和支援服務的需求格局。

公司簡介和競爭定位重點介紹了塑造非洲豬瘟病毒PCR診斷生態系統的創新路徑、夥伴關係和策略性舉措。

在非洲豬瘟病毒PCR診斷生態系中,各公司的定位反映了其在獨特檢測創新、策略夥伴關係和服務交付能力方面的平衡。領先的診斷開發人員透過嚴格的檢驗來強調檢測性能,注重供應鏈的穩健性,並針對現場、實驗室和研究環境開發應用特定的試劑盒,從而實現差異化競爭。同時,儀器製造商致力於實現互通性和開放平台策略,透過實現不同設備間的檢測轉移來降低試劑盒的使用門檻。試劑供應商和儀器供應商之間的合作協議加速了捆綁式產品的推出,從而減少了終端用戶的整合障礙。

為產業領導者最佳化非洲豬瘟病毒PCR診斷的檢測設計、供應彈性、市場進入和夥伴關係提供的實用建議

行業領導者應採取一系列切實可行的措施來增強診斷能力並提高商業性韌性。首先,優先發展模組化檢測組合,提供定性篩檢和定量後續檢測,以滿足不同終端使用者的需求,避免採用千篇一律的方法。其次,透過尋找替代供應商、建立區域庫存中心以及協商靈活的物流條款來增強供應鏈韌性,從而降低關稅和運輸中斷帶來的風險。第三,投資建造所有相關樣本基質(包括血清、全血、鼻拭子、口拭子以及淋巴結和脾臟組織)的檢驗資料集,以提供可靠的性能證據並加快監管核准。

調查方法概述,描述了資料來源、檢驗方法、專家參與以及支撐診斷結果的分析框架。

本分析所依據的研究結合了多層次的定性和定量方法,以確保得出平衡且切實可行的見解。主要研究包括與診斷開發、檢查室管理和獸醫公共衛生領域的專家進行結構化對話,並輔以專注於檢測方法檢驗、樣本處理和籌資策略的技術訪談。次要研究涵蓋了同行評審文獻、監管指導文件和公開的產品資料,檢驗技術特性、性能聲明和合規性考慮。透過對資訊來源進行三角驗證,並結合業界從業人員的反覆回饋進行交叉檢驗,最大限度地減少了偏差,並完善了主題結論。

總結了非洲豬瘟病毒 PCR 檢測的診斷意義、策略重點和新方向,供相關人員參考。

本篇回顧強調,非洲豬瘟病毒PCR診斷技術的關鍵在於技術性能、操作可行性與供應鏈穩定性三者之間的平衡。診斷創新者必須權衡先進的檢測能力(例如絕對定量和抑制劑抗性)與實際考慮(例如基質相容性、儀器互通性和培訓需求)。監管協調和跨樣本類型的檢驗證據對於加速公共和私人實驗室的推廣應用至關重要,而分銷服務模式將決定不同地理區域的實際可及性。

目錄

第1章:序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章 豬瘟病毒PCR試劑盒市場(依檢測類型分類)

  • 定性PCR
  • 定量PCR

9. 依技術分類的豬瘟病毒PCR試劑盒市場

  • 數位PCR
    • 液滴式數位PCR
    • 微流體數位PCR
  • 等溫PCR
    • 恒溫環型核酸擴增
    • 重組酶聚合酵素擴增
  • 即時PCR
    • SYBR Green
    • TaqMan探針

第10章 豬瘟病毒PCR試劑盒市場(依樣本類型分類)

    • 血清
    • 全血
  • 拭子
    • 鼻腔
    • 口腔
  • 組織
    • 淋巴結

第11章 豬瘟病毒PCR試劑盒市場(依通路分類)

  • 直銷
  • 經銷商
    • 全國經銷商
    • 區域經銷商
  • 線上銷售
    • 電子商務入口網站
    • 製造商官方網站

第12章 豬瘟病毒PCR試劑盒市場(依最終用戶分類)

  • 學術機構
    • 單一學科大學
    • 大學
  • 診斷實驗室
    • 政府實驗室
    • 私人實驗室
  • 醫院
    • 綜合醫院
    • 獸醫診所
  • 研究所
    • 政府研究所
    • 私人研究機構

第13章 豬瘟病毒PCR試劑盒市場(依地區分)

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 豬瘟病毒PCR試劑盒市場(按類別分類)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國豬瘟病毒PCR試劑盒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國豬瘟病毒PCR試劑盒市場

第17章:中國豬瘟病毒PCR試劑盒市場

第18章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Bio-Rad Laboratories, Inc.
  • BioChek BV
  • Bionote, Inc.
  • Biosellal
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • Krishgen Biosystems
  • Meridian Bioscience, Inc.
  • NZYtech, Lda
  • Qiagen NV
  • Ring BIoTechnology Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Vetnostics
  • Virbac SA
  • Xi'an Tianlong Science and Technology Co., Ltd
Product Code: MRR-92740D85F035

The African Swine Fever Virus PCR Kit Market was valued at USD 198.12 million in 2025 and is projected to grow to USD 216.24 million in 2026, with a CAGR of 6.39%, reaching USD 305.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 198.12 million
Estimated Year [2026] USD 216.24 million
Forecast Year [2032] USD 305.84 million
CAGR (%) 6.39%

Comprehensive introduction to the African Swine Fever Virus PCR kit landscape, emphasizing diagnostic necessity, performance standards and strategic utility

African Swine Fever Virus (ASFV) remains one of the most consequential animal health threats to commercial swine populations, and PCR-based diagnostics sit at the center of rapid detection, outbreak containment and export validation workflows. PCR kits designed specifically for ASFV enable laboratories and field testing units to detect viral DNA with a combination of sensitivity and speed that underpins public health responses, veterinary surveillance and trade compliance. The introduction of high-performance PCR assays over the past decade has shifted diagnostic practice from reactive confirmation to proactive surveillance, enabling earlier intervention and more precise epidemiological mapping.

As diagnostic requirements evolve, stakeholders across research, clinical diagnostics and veterinary services demand kits that balance analytical performance with operational practicality. Key considerations include limits of detection robustness in complex matrices, assay specificity against cross-reacting pathogens, and ease of integration with existing instrumentation platforms. Furthermore, the interplay between laboratory capacity and sample logistics - from tissue biopsies to swab and blood specimens - drives selection criteria that extend beyond raw analytical metrics. Consequently, a pragmatic understanding of kit performance, workflow fit, and supply continuity is essential for decision-makers aiming to strengthen biosecurity and preserve commercial continuity in swine production systems.

Analysis of transformative technological and regulatory shifts reshaping African Swine Fever Virus PCR kit development, deployment and diagnostic workflows

The diagnostic landscape for ASFV PCR kits is undergoing transformative shifts driven by rapid technology maturation, increasing regulatory scrutiny and changing end-user expectations. On the technological front, adoption patterns are moving from traditional real-time PCR toward specialized platforms that prioritize absolute quantification and resilience to inhibitors. This shift reflects a broader trend toward assays that not only detect presence or absence but also inform disease staging and viral load dynamics to guide containment strategies. In parallel, isothermal amplification modalities are gaining traction for decentralized testing due to their minimal equipment footprint and simplified thermal requirements, thereby extending diagnostic reach into lower-resource settings.

Regulatory ecosystems are also evolving to emphasize validated performance across matrix types and to require stronger documentation of manufacturing quality systems. Consequently, manufacturers are investing in standardized reference materials and expanded validation panels to meet more rigorous submission expectations. Operationally, supply chain resilience has moved to the top of the agenda; procurement teams now prioritize reagent traceability, multi-source component strategies and contingency inventory management. As a result, the market is seeing increased collaboration across diagnostics developers, instrument suppliers and distribution partners to create integrated solutions that reduce onboarding friction and accelerate time-to-result deployment. Taken together, these shifts are prompting a recalibration of product roadmaps, commercialization strategies and laboratory workflows to balance innovation with reliability and regulatory compliance.

Evaluating the cumulative impact of United States tariffs introduced in 2025 on supply chains, reagent sourcing, pricing and access to PCR diagnostic kits

Tariff changes introduced by the United States in 2025 have introduced a new layer of complexity for organizations sourcing ASFV PCR kits and related consumables. These measures influence cost structures across the value chain, elevating the importance of procurement strategy and supply diversification. For diagnostic developers and laboratory networks, the immediate operational response involves reassessing vendor contracts, evaluating regional sourcing alternatives and renegotiating logistics terms to mitigate landed-cost volatility. In practice, laboratories with centralized purchasing may shift toward multi-vendor strategies or localized reagent production to preserve affordability and continuity.

Beyond direct cost implications, tariff-driven price adjustments can alter competitive dynamics by providing incentive for manufacturers to optimize component sourcing or reconfigure manufacturing footprints. Some suppliers may respond by accelerating regional manufacturing partnerships or by qualifying alternative raw material suppliers that are tariff-neutral. Importantly, these adjustments affect not only price but also lead times and service levels, which in turn influence testing capacity and outbreak response timeliness. Strategic procurement now requires scenario planning that incorporates tariff escalation pathways, customs clearance contingencies and flexible inventory positioning to ensure diagnostic accessibility and maintain the integrity of surveillance programs.

Deep segmentation analysis revealing how technology, test type, sample type, end user and distribution channel distinctions drive adoption and product strategy

A granular segmentation view clarifies where innovation and demand converge across the ASFV PCR kit landscape. When examined by technology, the market encompasses Digital PCR, Isothermal PCR, and Real-Time PCR platforms; within Digital PCR, Droplet Digital PCR and Microfluidic Digital PCR offer distinct advantages in absolute quantification and partitioning strategies, while Isothermal PCR splits into Loop Mediated Isothermal Amplification and Recombinase Polymerase Amplification approaches that favor decentralized and low-resource deployment. Real-Time PCR maintains broad utility with SYBR Green and TaqMan Probe chemistries that balance cost, specificity and instrument compatibility. This technological heterogeneity shapes product positioning and informs instrumentation and consumable bundling strategies.

Viewing the market by test type further differentiates product applications into Qualitative PCR and Quantitative PCR assays, where qualitative formats prioritize presence/absence calls for regulatory screening and quantitative formats support viral load interpretation for outbreak management. Sample type segmentation-blood, swabs and tissue-drives assay design and validation focus; blood specimens are subdivided into serum and whole blood matrices that present distinct processing challenges, swab samples include nasal and oral collection sites with variable viral shedding patterns, and tissue specimens target lymph node and spleen matrices that are often prioritized for confirmatory diagnosis. End user segmentation reveals diverse procurement, operational and validation requirements across academic institutes, diagnostic labs, hospitals and research institutes; academic institute demand stems from college and university labs focused on method development and training, diagnostic lab demand arises from government and private laboratories that require throughput and accreditation support, hospital demand splits between general hospitals and veterinary hospitals needing rapid clinical decision support, and research institutes include both government research and private research entities that pursue advanced assay optimization.

Distribution channels complete the picture by shaping market access and service expectations; direct sales address large institutional customers requiring technical service and customization, distributors-organized as national and regional distributors-facilitate broader geographic reach and local regulatory navigation, and online sales channels such as e-commerce portals and manufacturer websites enable rapid replenishment and flexible ordering for smaller labs. Taken together, these segmentation lenses reveal multiple, sometimes overlapping pathways for adoption, where product developers must design modular portfolios and scalable supply models to meet the heterogeneous needs of laboratories, field teams and research groups.

Regional diagnostic landscapes compared to highlight demand drivers, regulatory complexity and infrastructure variations across global regions

Regional dynamics materially influence diagnostic access, operational constraints and go-to-market choices for ASFV PCR kits. In the Americas, diagnostic demand is shaped by integrated commercial swine production systems, cross-border trade considerations and established laboratory networks that emphasize throughput, accreditation and traceability. Consequently, solutions that deliver robust batch processing, standardized consumables and validated workflows find traction, while logistics sophistication supports just-in-time supply models. Transitioning north to south within the region, public sector surveillance programs and private sector consolidation create varying demand profiles for assay complexity and support services.

Across Europe, Middle East & Africa, regulatory complexity and resource heterogeneity create a dual reality: some markets require stringent conformity with regional and national regulatory frameworks and prefer kits with comprehensive validation packages, while other territories favor simplified, rugged assays that can perform in limited infrastructure contexts. In this diverse region, partnerships with national distributors and localized training programs improve adoption and ensure appropriate cold-chain and sample handling practices. Asia-Pacific illustrates a blend of advanced laboratory capacity and vast rural production zones. High-throughput reference labs in urban centers demand automation and rigorous data integration, whereas decentralized veterinary services benefit from portable isothermal or simplified real-time PCR kits. In all regions, investment in cold-chain logistics, training and regulatory alignment remains critical to expand reliable diagnostic coverage and to support rapid, coordinated responses to emerging outbreaks.

Company profiles and competitive positioning that reveal innovation pathways, partnerships and strategic moves shaping the ASFV PCR diagnostic ecosystem

Company positioning in the ASFV PCR diagnostic ecosystem reflects a balance between proprietary assay innovation, strategic partnerships and service delivery capabilities. Leading diagnostic developers emphasize assay performance through rigorous validation, concentrate on supply chain robustness and differentiate with application-specific kits that address field, laboratory and research settings. Meanwhile, instrument manufacturers pursue interoperability and open-platform strategies that lower barriers for kit adoption by enabling assay migration across devices. Collaborative agreements between reagent suppliers and instrument vendors accelerate bundled offerings that reduce integration friction for end users.

Competitive dynamics also favor organizations that invest in end-user support infrastructure such as on-site validation assistance, training programs and digital resources for remote troubleshooting. In addition, companies that establish multi-regional manufacturing or strategic distributor networks can reduce lead times and mitigate tariff or logistics disruptions. Smaller, specialized developers continue to drive niche innovation, particularly in isothermal chemistries and microfluidic partitioning, while larger firms use scale and regulatory experience to expand into new territories. This interplay of scale, specialization and service capability shapes strategic decisions around R&D investment, partnership formation and commercial expansion within the diagnostic space.

Actionable recommendations for industry leaders to optimize assay design, supply resilience, market access and collaborative partnerships in ASFV PCR diagnostics

Industry leaders should adopt a pragmatic set of actions to strengthen diagnostic readiness and commercial resilience. First, prioritize modular assay portfolios that provide both qualitative screening and quantitative follow-up options, thereby meeting the spectrum of end-user needs without forcing a single-size-fits-all approach. Second, build supply chain resilience by qualifying alternative suppliers, establishing regional inventory hubs, and negotiating flexible logistics terms to limit exposure to tariff or transport disruptions. Third, invest in validation datasets across relevant sample matrices-serum, whole blood, nasal and oral swabs, lymph node and spleen tissues-to provide robust evidence of performance and to accelerate regulatory acceptance.

Leaders should also enhance market access through diversified distribution strategies that combine direct sales for large institutional customers, partnerships with national and regional distributors for broader reach, and online channels to service smaller laboratories. Complementing product availability with training, accredited validation support and digital resources will increase user confidence and reduce onboarding friction. Finally, pursue targeted collaborations with academic institutions, government diagnostic labs and private research centers to foster real-world evidence generation and to catalyze adoption through trusted local networks. Together, these actions will strengthen competitive positioning while improving diagnostic reliability and responsiveness.

Methodology overview describing data sources, validation approaches, expert engagement and analytical frameworks that underpin the diagnostic insights

The research underpinning this analysis combined layered qualitative and quantitative approaches to ensure balanced, actionable insights. Primary research included structured engagement with subject matter experts across diagnostics development, laboratory management and veterinary public health, complemented by technical interviews focused on assay validation, sample handling and procurement strategies. Secondary research encompassed peer-reviewed literature, regulatory guidance documents and publicly available product dossiers to validate technology characteristics, performance claims and compliance considerations. Cross-validation occurred through triangulation of sources and iterative feedback from industry practitioners to minimize bias and to refine thematic conclusions.

Analytical frameworks prioritized segmentation by technology, test type, sample matrix, end user and distribution channel to reveal practical intersections between product design and operational deployment. Data integrity measures included verification of assay nomenclature, confirmation of subdivision attributes such as droplet versus microfluidic digital PCR and loop mediated versus recombinase isothermal approaches, and assessment of sample processing differences across serum, whole blood, swab and tissue matrices. Insights were synthesized to highlight strategic implications rather than to produce numerical forecasts, thereby delivering contextually rich guidance that supports tactical and strategic decision making in diagnostics and supply chain planning.

Concluding synthesis summarizing diagnostic implications, strategic priorities and the emerging path forward for stakeholders managing ASFV PCR testing challenges

This synthesis underscores that ASFV PCR diagnostics operate at the intersection of technical performance, operational feasibility and supply chain robustness. Diagnostic innovators must balance advanced assay capabilities-such as absolute quantification and inhibitor tolerance-with pragmatic considerations including matrix compatibility, instrument interoperability and training needs. Regulatory alignment and validated evidence across sample types are pivotal to accelerate acceptance across public and private laboratories, while distribution and service models determine real-world accessibility in diverse geographic contexts.

Looking forward, the most resilient strategies will combine modular product design, diversified sourcing and close partnerships with regional laboratory networks to ensure rapid deployment and sustained performance. By aligning assay portfolios to differentiated use cases and by strengthening logistical and validation infrastructures, manufacturers and diagnostic providers can meaningfully improve outbreak responsiveness and support long-term surveillance objectives. Ultimately, a coordinated approach that integrates technical excellence with operational discipline will deliver the most reliable path to safeguarding swine health and protecting the broader agricultural economy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. African Swine Fever Virus PCR Kit Market, by Test Type

  • 8.1. Qualitative Pcr
  • 8.2. Quantitative Pcr

9. African Swine Fever Virus PCR Kit Market, by Technology

  • 9.1. Digital Pcr
    • 9.1.1. Droplet Digital Pcr
    • 9.1.2. Microfluidic Digital Pcr
  • 9.2. Isothermal Pcr
    • 9.2.1. Loop Mediated Isothermal Amplification
    • 9.2.2. Recombinase Polymerase Amplification
  • 9.3. Real-Time Pcr
    • 9.3.1. SYBR Green
    • 9.3.2. TaqMan Probe

10. African Swine Fever Virus PCR Kit Market, by Sample Type

  • 10.1. Blood
    • 10.1.1. Serum
    • 10.1.2. Whole Blood
  • 10.2. Swabs
    • 10.2.1. Nasal
    • 10.2.2. Oral
  • 10.3. Tissue
    • 10.3.1. Lymph Node
    • 10.3.2. Spleen

11. African Swine Fever Virus PCR Kit Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National Distributor
    • 11.2.2. Regional Distributor
  • 11.3. Online Sales
    • 11.3.1. E-Commerce Portal
    • 11.3.2. Manufacturer Website

12. African Swine Fever Virus PCR Kit Market, by End User

  • 12.1. Academic Institute
    • 12.1.1. College
    • 12.1.2. University
  • 12.2. Diagnostic Lab
    • 12.2.1. Government Lab
    • 12.2.2. Private Lab
  • 12.3. Hospital
    • 12.3.1. General Hospital
    • 12.3.2. Veterinary Hospital
  • 12.4. Research Institute
    • 12.4.1. Government Research
    • 12.4.2. Private Research

13. African Swine Fever Virus PCR Kit Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. African Swine Fever Virus PCR Kit Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. African Swine Fever Virus PCR Kit Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States African Swine Fever Virus PCR Kit Market

17. China African Swine Fever Virus PCR Kit Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Bio-Rad Laboratories, Inc.
  • 18.6. BioChek B.V.
  • 18.7. Bionote, Inc.
  • 18.8. Biosellal
  • 18.9. Eppendorf SE
  • 18.10. F. Hoffmann-La Roche Ltd.
  • 18.11. IDEXX Laboratories, Inc.
  • 18.12. INDICAL BIOSCIENCE GmbH
  • 18.13. Innovative Diagnostics SAS
  • 18.14. Krishgen Biosystems
  • 18.15. Meridian Bioscience, Inc.
  • 18.16. NZYtech, Lda
  • 18.17. Qiagen N.V.
  • 18.18. Ring Biotechnology Co., Ltd.
  • 18.19. Thermo Fisher Scientific, Inc.
  • 18.20. Vetnostics
  • 18.21. Virbac S.A.
  • 18.22. Xi'an Tianlong Science and Technology Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUALITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUALITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUALITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MICROFLUIDIC DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MICROFLUIDIC DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MICROFLUIDIC DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RECOMBINASE POLYMERASE AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SYBR GREEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SYBR GREEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SYBR GREEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TAQMAN PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TAQMAN PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TAQMAN PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LYMPH NODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LYMPH NODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY LYMPH NODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SPLEEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SPLEEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SPLEEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY E-COMMERCE PORTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY E-COMMERCE PORTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY E-COMMERCE PORTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COLLEGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COLLEGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COLLEGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY UNIVERSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY UNIVERSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY UNIVERSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GENERAL HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GENERAL HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY VETERINARY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY VETERINARY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GOVERNMENT RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY PRIVATE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SWABS, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ACADEMIC INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY ISOTHERMAL PCR, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN AFRICAN SWINE FEVER VIRUS PCR KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)

TABLE 290.